Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will initiate a Phase IIb clinical trial for ZoraxelTM in the treatment of erectile dysfunction (ED).

13 May 2010

Data on Qnexa to be presented at World Congress on CODHy in Prague

VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension in Prague, Czech Republic.

13 May 2010

Study: PDE5 inhibitors may increase permeability of blood brain barrier to Herceptin

New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.

10 May 2010

Creator of California Tay-Sachs Disease Prevention Program among the honorees

A mere 40 years ago, parents didn't know they were carriers of the Tay-Sachs disease until after they'd given birth to a child with this fatal genetic disorder.

7 May 2010

Warner Chilcott reports 209.5% increase in first-quarter 2010 revenues

Warner Chilcott plc today announced its results for the quarter ended March 31, 2010. Revenue in the quarter was $761.3 million, an increase of $515.3 million, or 209.5%, over the prior year quarter.

7 May 2010

Today's Opinions and Editorials: The end of insurance rescissions, lessons from the health care rollout and the deficit panel's tough decisions

A lot of people laughed when Sue Lowden, the Nevada Republican running for the U.S. Senate, suggested last month that people start paying for their medical care with chickens. I didn't (Jonathan Cohn, 5/3).

3 May 2010

SGB procedure holds potential promise for PTSD treatment

Walter Reed Army Medical Center in Bethesda, MD, has published case reports detailing the successful treatment of combat-related post-traumatic stress disorder with a stellate ganglion block.

3 May 2010

Men with erectile dysfunction, low testosterone at higher risk of death from cardiovascular disease

Research presented at the European Congress of Endocrinology shows for the first time that men with erectile dysfunction and low testosterone have a higher than normal risk of dying from cardiovascular disease. Further work from the same research group shows that obesity is also associated with an impairment of blood flow to the penis, which in turn is also associated with cardiovascular disease in men with erectile dysfunction.

27 Apr 2010

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

26 Apr 2010

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

Ampio Pharmaceuticals, Inc., today announced that it has entered into a letter of intent to acquire DMI Biosciences, Inc.

23 Apr 2010

Lipocine announced receipt of $2M development milestone payment from Abbott

Lipocine Inc. announced today the receipt of a $2 million development milestone payment from Abbott under the terms of its Licensing Agreement to develop and commercialize an oral testosterone product for hypogonadism, also known as low testosterone.

21 Apr 2010

Democrats, Republicans using health reform votes to plot November strategies

The Associated Press: Vulnerable Democrats around the country are "tiptoeing" during the recess as they prepare for midterm elections. "Tough votes for Obama's health care plan have further complicated the re-election prospects of dozens of already vulnerable freshman and second-term Democrats. There's even a chance the party could lose control of one or both houses in the midterm elections."

9 Apr 2010

Study: 75% of men with diabetes will develop some degree of ED

Erectile dysfunction is one of the most prevalent diabetes-induced complications in men; current estimates suggest that as many as 75% of men with diabetes will develop some degree of ED, and in many cases diabetics develop more severe forms of ED that are less responsive to standard drugs.

7 Apr 2010

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.

2 Apr 2010

VIVUS terminates Luramist development, commercialization agreement with FemPharm

VIVUS, Inc. today announced that it has terminated the Development and Commercialization Agreement with FemPharm Pty Ltd. (a wholly owned subsidiary of Acrux Limited) for Luramist™, a metered dose transdermal application of testosterone for women.

1 Apr 2010

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Former England Rugby World Cup winner Matt Dawson today launched the 'Because Life is for Living' campaign to raise awareness about brachytherapy, a very precise and highly effective form of radiotherapy to treat cancer.

30 Mar 2010

FDA Advisory Committee to review VIVUS' NDA for Qnexa

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.

26 Mar 2010

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.

26 Mar 2010

Senate passes health reform reconciliation bill, sends it back to House

The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.

26 Mar 2010

It's over: House passes last piece of landmark health reform, 220-207

Politico: "Congress completed its work Thursday night on the broadest social legislation in almost a half-century, as the House capped the year-long legislative saga over health reform by signing off on a package of fixes to the newly minted law. In the end, the titanic battle over remaking the American health care system drew to a close on a pair of votes drained of suspense - after the Senate approved the clean-up bill earlier Thursday. The House approved the clean-up bill, 220 to 207" (Budoff Brown, 3/25).

26 Mar 2010

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Data on Qnexa to be presented at World Congress on CODHy in Prague

Study: PDE5 inhibitors may increase permeability of blood brain barrier to Herceptin

Creator of California Tay-Sachs Disease Prevention Program among the honorees

Warner Chilcott reports 209.5% increase in first-quarter 2010 revenues

Today's Opinions and Editorials: The end of insurance rescissions, lessons from the health care rollout and the deficit panel's tough decisions

SGB procedure holds potential promise for PTSD treatment

Men with erectile dysfunction, low testosterone at higher risk of death from cardiovascular disease

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

Lipocine announced receipt of $2M development milestone payment from Abbott

Democrats, Republicans using health reform votes to plot November strategies

Study: 75% of men with diabetes will develop some degree of ED

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

VIVUS terminates Luramist development, commercialization agreement with FemPharm

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

FDA Advisory Committee to review VIVUS' NDA for Qnexa

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Senate passes health reform reconciliation bill, sends it back to House

It's over: House passes last piece of landmark health reform, 220-207

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in